Free Trial

Hemispherx BioPharma (HEB) News Today

Hemispherx BioPharma logo
$0.21 0.00 (0.00%)
(As of 11/22/2024 ET)
H-E-B hosting hiring fairs
Hemispherx's Ampligen Dealt FDA Blow
H-E-B plans to hire 700 for its McKinney store
Get Hemispherx BioPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for HEB and its competitors with MarketBeat's FREE daily newsletter.

2025: Digital Asset Insights You Need to Know (Ad)

Cryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto. Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential.

Get your guide today!

HEB Media Mentions By Week

HEB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HEB
News Sentiment

0.00

0.49

Average
Medical
News Sentiment

HEB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HEB Articles
This Week

0

0

HEB Articles
Average Week

Get Hemispherx BioPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for HEB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSEAMERICAN:HEB) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners